5-alpha-reductase and the development of the human prostate

por Radmayr, C., Lunacek, A., Schwentner, C., Oswald, J., Klocker, H., Bartsch, G.
Publicado 2008

Expression of transforming growth factors beta-1, beta 2 and beta 3 in human bladder carcinomas.

por Eder, I. E., Stenzl, A., Hobisch, A., Cronauer, M. V., Bartsch, G., Klocker, H.
Publicado 1997

Androgen receptor protein is down-regulated by basic fibroblast growth factor in prostate cancer cells

por Cronauer, M V, Nessler-Menardi, C, Klocker, H, Maly, K, Hobisch, A, Bartsch, G, Culig, Z
Publicado 2000

Switch from antagonist to agonist of the androgen receptor blocker bicalutamide is associated with prostate tumour progression in a new model system

por Culig, Z, Hoffmann, J, Erdel, M, Eder, I E, Hobisch, A, Hittmair, A, Bartsch, G, Utermann, G, Schneider, M R, Parczyk, K, Klocker, H
Publicado 1999

Interleukin 1beta mediates the modulatory effects of monocytes on LNCaP human prostate cancer cells.

por Culig, Z., Hobisch, A., Herold, M., Hittmair, A., Thurnher, M., Eder, I. E., Cronauer, M. V., Rieser, C., Ramoner, R., Bartsch, G., Klocker, H., Konwalinka, G.
Publicado 1998

Resistance to the mTOR-inhibitor RAD001 elevates integrin α2- and β1-triggered motility, migration and invasion of prostate cancer cells

por Tsaur, I, Makarević, J, Juengel, E, Gasser, M, Waaga-Gasser, A-M, Kurosch, M, Reiter, M, Wedel, S, Bartsch, G, Haferkamp, A, Wiesner, C, Blaheta, R A
Publicado 2012